LongeVC
Investment Focus
Sectors
Geographic Focus
Inferred Thesis
Auto-generated from public data. Not the firm's stated position.
Based on disclosed data, LongeVC appears to focus on life sciences and healthtech companies leveraging artificial intelligence and data analytics, with particular emphasis on longevity and drug discovery applications. Recent portfolio suggests investment activity across series-a through growth stages with typical check sizes between €1.5M and €3.0M. The investor's geographic base in Switzerland and sector concentration indicate a specialized thesis around computational biology and aging-related technologies.
Generated 8 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
How to Pitch LongeVC
Who To Contact
YC Portfolio Overlap
LongeVC backed 2 Y Combinator companies.
Blood Test for Early Detection of Ovarian Cancer
At-Home health monitoring with silicon photonic chips for data centers
Portfolio Highlights
Team
Auto-detected from LongeVC's website.
Focus and check size from the firm's website. Website reachable as of Oct 2026.
Ready to Reach LongeVC?
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.